Stocks of AMGEN Inc (NASDAQ:AMGN) traded higher last session on Wall Street, down -0.02% to $278.26.
AMGN stock price is now -9.99% away from the 50-day moving average and -8.96% away from the 200-day moving average. The market capitalization of the company currently stands at $149.57B.
On November 14, 2024, Citigroup recently initiated its ‘Neutral’ rating on the stock quoting a target price of $335, while ‘Bernstein’ rates the stock as ‘Outperform’
In other news, Grygiel Nancy A., SVP & CCO sold 2,117 shares of the company’s stock on May 03 ’24. The stock was sold for $662,802 at an average price of $313.09. Upon completion of the transaction, the SVP & CCO now directly owns 9,883 shares in the company, valued at $2.75 million. A total of 0.26% of the company’s stock is owned by insiders.
During the past 12 months, AMGEN Inc has had a low of $257.80 and a high of $346.85. As of last week, the company has a debt-to-equity ratio of 8.02, a current ratio of 1.32, and a quick ratio of 0.96. According to the stock market information, the enterprise value for the company is $200993112064, which is based on a 35.63 price-to-earnings ratio, a 7.13 price-to-earnings-growth ratio, and a beta of 0.54. The fifty day moving average price for AMGN is $310.1886 and a two-hundred day moving average price translates $305.6603 for the stock.
The latest earnings results from AMGEN Inc (NASDAQ: AMGN) was released for 2024-09-30. The net profit margin was 13.09% and return on equity was 55.72% for AMGN. The company reported revenue of $8.5 billion for the quarter, compared to $6.9 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 23.18 percent.
